Researchers warned that to achieve such reductions, greater uptake of the medication among indicated patients is needed.

INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list. Hundreds of ...